ARALYTE Trademark

Trademark Overview


On Wednesday, July 29, 2015, a trademark application was filed for ARALYTE with the United States Patent and Trademark Office. The USPTO has given the ARALYTE trademark a serial number of 86708156. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 16, 2023. This trademark is owned by Antera Therapeutics, Inc.. The ARALYTE trademark is filed in the Pharmaceutical Products category with the following description:

Allergy medications
aralyte

General Information


Serial Number86708156
Word MarkARALYTE
Filing DateWednesday, July 29, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 16, 2023
Registration Number5096564
Registration DateTuesday, December 6, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2016

Trademark Statements


Goods and ServicesAllergy medications
Translation of Words in MarkThe wording "ARALYTE" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 16, 2023
Primary Code005
First Use Anywhere DateTuesday, August 23, 2016
First Use In Commerce DateTuesday, August 23, 2016

Trademark Owner History


Party NameSTALLERGENES GREER PLC
Party Type32 - New Owner After Registration
Legal Entity Type84 - NOT AVAILABLE
AddressLONDON E1W 1DD
GB

Party NameADEO HEALTH SCIENCE, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBOSTON, MA 02116

Party NameAntera Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02134

Party NameAntera Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02134

Party NameAntera Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02134

Trademark Events


Event DateEvent Description
Friday, June 16, 2023CANCELLED SEC. 8 (6-YR)
Monday, December 6, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, May 15, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, April 5, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 6, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, November 3, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, November 2, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 21, 2016STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 6, 2016USE AMENDMENT FILED
Friday, October 21, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 6, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, August 30, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 15, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 31, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 23, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 19, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 19, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 17, 2016ASSIGNED TO LIE
Wednesday, May 4, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 2, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 2, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 12, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 12, 2015NON-FINAL ACTION E-MAILED
Thursday, November 12, 2015NON-FINAL ACTION WRITTEN
Monday, November 9, 2015ASSIGNED TO EXAMINER
Tuesday, August 4, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 3, 2015NEW APPLICATION ENTERED

Related Keywords


aralyte medications allergy